You are here: Industry Insights > NICE

News List

NICE joins international collaboratives to respond to COVID-19 europeanpharmaceuticalreview
May 05, 2020
NICE in the UK has announced it will partner with international collaborations to share its work on COVID-19 and develop guidelines for healthcare professionals.
NICE backs NHS use of Bayer's Vitrakvi via the CDF pharmatimes
April 26, 2020
Bayer's Vitrakvi (larotrectinib) will be available via the NHS in England and Wales to treat a variety of cancers.
NICE publishes new COVID-19 guidelines pharmatimes
April 24, 2020
The National Institute of Health and Care Excellence (NICE) has published new rapid COVID-19 guidelines covering the management of disorders of the digestive system treated with drugs that affect the immune response ...
NICE recommends Vitrakvi (larotrectinib) for use on Cancer Drugs Fund europeanpharmaceuticalreview
April 22, 2020
Larotrectinib has been given a positive opinion by NICE, following the submission of a revised price after it was previously rejected.
NICE publishes four more rapid guidelines in response to pandemic pharmatimes
April 07, 2020
The National Institute for Health and Care Excellence (NICE) has published four new rapid guidelines on the active management of patients with suspected and confirmed COVID-19, and in patients without COVID-19.
NICE publishes second set of rapid COVID-19 guidelines pharmatimes
April 02, 2020
The National Institute for Health and Care Excellence (NICE) has published its second set of rapid guidelines to cover the provision of radiotherapy services and bone marrow transplant during the COVID-19 pandemic.
COVID-19: NICE updates guideline as Sanofi announces vaccine development pharmatimes
March 31, 2020
As the number of deaths in the UK more than doubled over the weekend, The National Institute for Health and Care Excellence (NICE) has updated its rapid COVID-19 critical care guideline.
Professor Gillian Leng appointed NICE Chief Executive europeanpharmaceuticalreview
March 20, 2020
Professor Gillian Leng has been appointed as the new Chief Executive of NICE and will take over from Sir Andrew Dillon in early April.
NICE fails to recommend pembrolizumab in final draft guidance europeanpharmaceuticalreview
March 17, 2020
The UK NICE has not found pembrolizumab cost-effective for use on the NHS, after a review of evidence collected while the drug was available via the Cancer Drugs Fund.
NICE recommends fremanezumab for chronic migraine prevention europeanpharmaceuticalreview
March 16, 2020
The UK’s National Institute for Health and Care Excellence, NICE, recommends the use of fremanezumab on the NHS for preventing chronic migraine.

Previous page 1 2 3 4 5 6 7 8 9 10 ... 41 42 Next page